Nicolet Bankshares’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Nicolet Bankshares's REGN Position: Q2 2026 in Review
Nicolet Bankshares reduced its Regeneron Pharmaceuticals (REGN) stake by 3% in Q2 2026, selling an estimated $14.3K and leaving 684 shares worth $427K. The position accounts for 0.01% of the portfolio, ranked #437.
Nicolet Bankshares first reported a position in REGN in Q1 2026 and has held it in 2 quarters since. The position peaked at $545K in Q1 2026. 1,336 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Nicolet Bankshares held 684 shares of Regeneron Pharmaceuticals worth $427K as of Q2 2026.
- Nicolet Bankshares sold 21 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $14.3K.
- Regeneron Pharmaceuticals made up 0.01% of Nicolet Bankshares's portfolio in Q2 2026, its #437 holding.
- Nicolet Bankshares first reported a position in Regeneron Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
- Nicolet Bankshares's Regeneron Pharmaceuticals position peaked at $545K in Q1 2026.
- 1,336 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Nicolet Bankshares's 13F filing for Q2 2026, filed 11 Aug 2026.